United States Non-invasive Glucose Monitoring Devices Market 2033 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth 2026

The global non-invasive glucose monitoring devices market reached US$ 29.53 Million in 2023, with a rise of US$ 31.57 Million in 2024 and is expected to reach US$ 60.71 Million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

DataM Intelligence has released a new research report titled non-invasive glucose monitoring devices Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global non-invasive glucose monitoring devices market.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/non-invasive-glucose-monitoring-devices-market?sb

Key Developments 2025-2026:

United States: Recent Industry Developments

✅ In July 2026, Know Labs advanced its Bio-RFIDTM non-invasive glucose monitoring platform through ongoing clinical validation and regulatory preparation. The technology is designed to measure blood glucose levels without finger pricks using radio-frequency sensing. The company continues to strengthen partnerships aimed at commercial deployment in healthcare settings.

✅ In June 2026, Abbott announced expanded research initiatives focused on next-generation non-invasive glucose monitoring technologies alongside its continuous glucose monitoring portfolio. The company is investing in innovative biosensing platforms to improve diabetes management. These efforts support the long-term transition toward needle-free glucose monitoring solutions.

✅ In May 2026, Medtronic increased investments in advanced diabetes technologies, including research into non-invasive and minimally invasive glucose sensing systems. The company is integrating AI-driven analytics with future glucose monitoring platforms to improve accuracy and personalized care. The initiative reflects growing demand for convenient diabetes management solutions.

Japan: Recent Industry Developments

✅ In July 2026, Nipro Corporation expanded R&D activities for next-generation glucose monitoring technologies focused on improving patient comfort and monitoring accuracy. The company is evaluating advanced optical sensing methods for future non-invasive applications. The development supports Japan's growing emphasis on digital diabetes care.

✅ In June 2026, Terumo Corporation strengthened investments in digital diabetes management technologies, including innovative biosensor research for future non-invasive glucose monitoring devices. The initiative combines wearable healthcare solutions with real-time patient monitoring capabilities. The company aims to enhance diabetes care through continuous innovation.

✅ In May 2026, Sony Group Corporation continued collaborative research on advanced optical sensing technologies with potential applications in non-invasive health monitoring. The developments focus on improving sensor precision for future wearable medical devices. The research highlights Japan's growing role in next-generation digital healthcare innovation.

Ready to scale in the non-invasive glucose monitoring devices Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/non-invasive-glucose-monitoring-devices-market?sb

List of Key Players 2026:

=> Know Labs, Inc., Conga Medical Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Medtronic, Abbott Laboratories, Dexcom, Inc., Afon Technology, Ascensia Diabetes Care, and BlueSemi among others.

Growth Forecast Projection 2026:

The Global non-invasive glucose monitoring devices Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

How Our Market Research Process Works:

The global non-invasive glucose monitoring devices Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the non-invasive glucose monitoring devices ecosystem.

Recent Mergers & Acquisitions (M & A) 2025-2026:

✅ May 2026 - DexCom acquired digital health startup Nanowear to strengthen its wearable biosensing capabilities and accelerate the development of next-generation non-invasive glucose monitoring technologies.

✅ April 2026 - Medtronic acquired a minority stake in a European optical biosensor developer, expanding its portfolio of non-invasive metabolic monitoring and wearable diagnostics solutions.

✅ March 2026 - Abbott completed the acquisition of an AI-enabled digital health company to enhance glucose data analytics and support future non-invasive glucose monitoring platforms.

✅ February 2026 - Roche acquired a digital diagnostics and biosensor technology firm to strengthen its diabetes care business and accelerate innovation in non-invasive glucose monitoring.

✅ January 2026 - Siemens Healthineers expanded its wearable diagnostics portfolio through the acquisition of a health monitoring technology company focused on optical sensing and remote patient monitoring.

Request Strategic Market Customization: https://datamintelligence.com/customize/non-invasive-glucose-monitoring-devices-market?sb

Major Focused Key Segmentations 2026:

By Product Type

Wearable Devices - 78% Share
Wearable devices dominate the market owing to increasing demand for continuous, real-time glucose monitoring without invasive finger-prick methods. Advancements in smart sensors, artificial intelligence, and wireless connectivity have significantly improved user convenience and monitoring accuracy. Rising adoption among diabetic patients seeking continuous health insights and integration with smartphones and wearable ecosystems continues to drive segment growth globally.

Non-Wearable Devices - 22% Share
Non-wearable devices maintain a significant market presence owing to their affordability, ease of use, and growing adoption across healthcare facilities for periodic glucose monitoring. Continuous technological improvements are enhancing measurement accuracy and expanding their utilization across clinical settings.

By Technology

Optical - 36% Share
Optical technology dominates the market owing to its high accuracy, non-invasive measurement capabilities, and extensive research supporting near-infrared, Raman spectroscopy, and photoacoustic sensing technologies. Increasing commercialization of optical glucose monitoring solutions continues to strengthen segment leadership.

Transdermal - 24% Share
Transdermal technologies are witnessing rapid growth driven by their ability to measure glucose through the skin without blood sampling. Continuous innovations in biosensing materials and wearable patches are accelerating adoption across consumer healthcare applications.

Enzymatic - 17% Share
Enzymatic technologies continue to play a significant role owing to their proven reliability and established clinical validation. Advancements in minimally invasive biosensors are further supporting segment expansion.

Electromagnetic - 10% Share
Electromagnetic sensing technologies are gaining traction owing to ongoing research focused on improving non-invasive glucose detection accuracy and real-time monitoring capabilities.

Thermal - 8% Share
Thermal sensing technologies continue to evolve through advancements in physiological signal analysis, offering promising opportunities for future non-invasive glucose monitoring applications.

Ultrasound - 5% Share
Ultrasound-based glucose monitoring remains an emerging segment supported by increasing research and development activities aimed at enhancing measurement precision and clinical reliability.

By Application

Type 2 Diabetes - 61% Share
Type 2 diabetes dominates the market owing to its high global prevalence and increasing demand for convenient, continuous glucose monitoring solutions. Growing awareness regarding diabetes management, rising obesity rates, and expanding adoption of digital healthcare technologies continue to drive segment growth worldwide.

Type 1 Diabetes - 24% Share
Type 1 diabetes maintains substantial market share driven by the need for continuous glucose monitoring to optimize insulin therapy and reduce hypoglycemic events. Increasing adoption of wearable monitoring devices continues to support market expansion.

Prediabetes - 9% Share
Prediabetes is witnessing significant growth owing to rising awareness of early diabetes detection and preventive healthcare strategies. Increasing health screening initiatives are expected to accelerate segment development.

Gestational Diabetes - 6% Share
Gestational diabetes continues to experience steady growth driven by increasing maternal healthcare awareness and the growing prevalence of pregnancy-related diabetes worldwide.

By End User

Home Care Settings - 49% Share
Home care settings dominate the market owing to increasing patient preference for convenient, self-managed diabetes monitoring solutions. Rising adoption of wearable glucose monitoring devices, telehealth services, and remote patient monitoring technologies continues to strengthen segment leadership globally.

Hospitals & Clinics - 31% Share
Hospitals and clinics maintain significant market share driven by increasing diabetes diagnosis rates and the widespread use of advanced glucose monitoring systems for inpatient and outpatient care.

Diagnostic Centers - 12% Share
Diagnostic centers continue to witness steady growth owing to increasing demand for routine diabetes screening and early disease detection across preventive healthcare programs.

Research Institutes - 8% Share
Research institutes contribute to market growth through continuous development of next-generation non-invasive glucose monitoring technologies and clinical validation studies.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=non-invasive-glucose-monitoring-devices-market?sb

By Region

North America - 40% Share
North America dominates the market owing to the high prevalence of diabetes, advanced healthcare infrastructure, and rapid adoption of wearable medical technologies. Strong investments in digital health, favorable reimbursement policies, and the presence of leading medical device manufacturers continue to support regional market leadership.

Europe - 27% Share
Europe maintains significant market share driven by increasing healthcare expenditure, growing awareness of diabetes management, and expanding adoption of innovative glucose monitoring technologies. Supportive regulatory frameworks further contribute to regional growth.

Asia-Pacific - 23% Share
Asia-Pacific is the fastest-growing regional market owing to the rapidly increasing diabetic population, improving healthcare infrastructure, and rising adoption of digital healthcare solutions across China, India, Japan, and South Korea. Growing government initiatives promoting diabetes management are expected to accelerate market expansion.

South America - 6% Share
South America is witnessing steady growth supported by improving healthcare accessibility, increasing diabetes awareness programs, and rising adoption of advanced diagnostic technologies.

Middle East & Africa - 4% Share
The Middle East & Africa region is experiencing gradual market expansion driven by the growing burden of diabetes, increasing investments in healthcare infrastructure, and improving access to advanced glucose monitoring technologies across emerging economies.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

FAQ

Q1: What is the current size of the non-invasive glucose monitoring devices Market?

A: The non-invasive glucose monitoring devices Market was valued at US$ 31.57 Million in 2024 and is forecasted to hit US$ 60.71 Million by 2033

Q2: How rapidly will the Market expanding?

A: The non-invasive glucose monitoring devices market is projected to grow at a CAGR of 7.5% between 2025 and 2033.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?sb

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.